Protara Therapeutics, Inc. Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay
Protara Therapeutics, Inc. (TARA) reported Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay of 4.00% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-10.
Financial Statements › Notes › Compensation Related Costs › Defined Contribution Plan
us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent · last filed 2026-03-10
- Protara Therapeutics, Inc. defined contribution plan, employer matching contribution, percent of employees' gross pay for fiscal 2025 was 4.00%, a 0.00% change from fiscal 2024.
- Protara Therapeutics, Inc. defined contribution plan, employer matching contribution, percent of employees' gross pay for fiscal 2024 was 4.00%, a 0.00% change from fiscal 2023.
- Protara Therapeutics, Inc. defined contribution plan, employer matching contribution, percent of employees' gross pay for fiscal 2023 was 4.00%.
- Protara Therapeutics, Inc. defined contribution plan, employer matching contribution, percent of employees' gross pay for fiscal 2014 was 3.00%.
| Period end | Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay 12 month |
|---|---|
| 2025-12-31 | 4.00% 10-K · filed 2026-03-10 |
| 2024-12-31 | 4.00% 10-K · filed 2025-03-05 |
| 2023-12-31 | 4.00% 10-K · filed 2024-03-13 |
| 2014-12-31 | 3.00% 10-K · filed 2015-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |